Citadel Advisors’s MediWound MDWD Stock Holding History

Citadel Advisors’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,400	Closed	-$221K	–	13565
2025 Q2	$221K	Buy	11,400 +4,500	+65%	+$84.8K	﹤0.01%	10471
2025 Q1	$107K	Buy	+6,900	New	+$123K	﹤0.01%	11360
2024 Q4	–	Sell	-9,700	Closed	-$175K	–	15039
2024 Q3	$175K	Buy	9,700 +5,400	+126%	+$98.6K	﹤0.01%	10341
2024 Q2	$66.7K	Buy	4,300 +3,700	+617%	+$61.2K	﹤0.01%	11432
2024 Q1	$8.55K	Buy	+600	New	+$8.22K	﹤0.01%	13546
2022 Q3	–	Sell	-1,714	Closed	-$22K	–	13206
2022 Q2	$22K	Buy	1,714 +257	+18%	+$3.4K	﹤0.01%	12363
2022 Q1	$20K	Buy	+1,457	New	+$23.6K	﹤0.01%	13240

Other funds holding MDWD

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's MDWD Position: Q1 2026 in Review

Citadel Advisors reduced its MediWound (MDWD) stake by 34% in Q1 2026, selling an estimated $529K and leaving 59,240 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #7760.

Citadel Advisors first reported a position in MDWD in Q1 2014 and has held it in 23 quarters since. The position peaked at $8.19M in Q1 2014. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

Citadel Advisors held 59,240 shares of MediWound worth $954K as of Q1 2026.
Citadel Advisors sold 30,398 MediWound shares in Q1 2026, an estimated $529K.
MediWound made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7760 holding.
Citadel Advisors first reported a position in MediWound in Q1 2014 and has held it in 23 quarters since.
Citadel Advisors's MediWound position peaked at $8.19M in Q1 2014.
76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.